Trial Profile
Clopidogrel and the Optimization of Gastrointestinal EveNts Trial 2
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 20 Nov 2007
Price :
$35
*
At a glance
- Drugs Clopidogrel/omeprazole (Primary) ; Aspirin; Clopidogrel
- Indications Acute coronary syndromes; Embolism and thrombosis; Gastrointestinal haemorrhage
- Focus Registrational; Therapeutic Use
- Acronyms COGENT-2
- Sponsors Cogentus Pharmaceuticals
- 20 Nov 2007 New trial record.